000			02281nam a2200445 i 4500
999			_c292375 _d292375
001			ocm80158883
003			OCoLC
005			20200423131250.0
006			m o d f
007			cr |||||||||||
008			070126s2006 dcua ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cZCY _dZCY _dOCLCQ _dOCLCA _dOCLCQ _dOCLCF _dGPO _dMvI
042			_apcc
043			_an-us---
074			_a0718-C-01 (online)
086	0		_aJ 37.2:P 49
099			_aJ 37.2:P 49
110	1		_aUnited States. _bDepartment of Justice. _bEvaluation and Inspections Division,
245	1	0	_aFollow-up review of the Drug Enforcement Administration's efforts to control the diversion of controlled pharmaceuticals / _cU.S. Department of Justice, Office of the Inspector General, Evaluation and Inspection Division.
264		1	_a[Washington, D.C.] : _bU.S. Department of Justice Office of the Inspector General, Evaluation and Inspections Division, _c2006.
300			_a1 online resource (vii, 79 pages) : _billustrations.
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
490	1		_aReport ; _vI-2006-004
500			_a"July 2006."
500			_aReport number from the Office of Inspector General, U.S. Department of Justice's "All reports" page.
500			_aIncludes tables.
500			_aGPO Cataloging Record Distribution Program (CRDP).
504			_aIncludes bibliographical references.
588			_aDescription based on online resource; title from PDF cover (OIG.JUSTICE.gov website, viewed January 14, 2007).
776	0	8	_iPrint version: _aUnited States. Department of Justice. Office of the Inspector General. _tFollow-up review of the Drug Enforcement Administration's efforts to control the diversion of controlled pharmaceuticals _w(OCoLC)80184669
830		0	_aReport (United States. Department of Justice. Office of the Inspector General) ; _vI-2006-004.
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo133948
610	1	0	_aUnited States. _bDrug Enforcement Administration _xManagement _xEvaluation.
650		0	_aDrug control _zUnited States.
650		0	_aInternet pharmacies _xCorrupt practices _zUnited States.
650		0	_aDrug traffic _xInvestigation _zUnited States.
942			_2sudocs _c8